Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials
- Conditions
- Bile Duct Cancer
- Registration Number
- NCT05706974
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative.
The goal is to identify the obstacles and challenges that prevent participation in bile duct cancer clinical trials, as well as the reasons for withdrawal or discontinuation.
The insights gained from this study will ultimately benefit those with bile duct cancer who may be invited to participate in medical research in the years to come.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Age ≥ 18 years
- Signed written informed consent
- Patient has been diagnosed with bile duct cancer
- Woman pregnant or susceptible to the being
- Inability to perform regular electronic reporting
- Inclusion in another investigational clinical trial
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of bile duct cancer patients who decide to enroll in a clinical study 3 months Rate of bile duct cancer patients who remain in a clinical study to completion 12 months
- Secondary Outcome Measures
Name Time Method